Welcome to our dedicated page for Zimmer Biomet news (Ticker: ZBH), a resource for investors and traders seeking the latest updates and insights on Zimmer Biomet stock.
Zimmer Biomet Holdings, Inc. (ZBH) is a global innovator in musculoskeletal healthcare, delivering advanced orthopedic solutions for nearly a century. This news hub provides investors and medical professionals with timely updates on product developments, regulatory milestones, and strategic initiatives shaping the future of surgical care.
Track critical updates including quarterly earnings, FDA clearances for robotic surgery systems, and partnerships advancing AI-driven orthopedic solutions. Our curated feed consolidates press releases about joint reconstruction technologies, trauma care innovations, and global market expansions to inform your analysis of this medtech leader.
Discover how Zimmer Biomet’s integration of digital surgery platforms with traditional orthopedic expertise continues to redefine patient outcomes. Bookmark this page for direct access to verified updates about ZBH’s clinical advancements, without promotional commentary or speculative content.
Zimmer Biomet, a global leader in medical technology, announced plans to present at two key healthcare conferences. The management team will participate in the Bank of America Securities 2023 Healthcare Conference on May 10, 2023, at 1:40 p.m. ET. They will also present at the Jefferies Healthcare Conference on June 7, 2023. Investors can access a live webcast of both presentations on the ZBH Investor Relations website, with archived replays available after the events. With over 90 years of experience, Zimmer Biomet focuses on advancing patient mobility through innovative products and integrated technologies.
Zimmer Biomet Holdings (NYSE: ZBH), a leader in medical technology, will present at the Needham Virtual Healthcare Conference on April 18, 2023, at 10:15 a.m. ET. The presentation will be made by members of Zimmer Biomet's management team and will be accessible via their Investor Relations website. The conference aims to showcase innovative healthcare solutions that enhance patient mobility and health. Zimmer Biomet has a legacy of over 90 years in providing quality medical solutions and operates in 25+ countries worldwide, demonstrating their commitment to innovation.
Zimmer Biomet Holdings has announced that its first-quarter earnings conference call will be webcast on May 2, 2023, at 8:30 a.m. ET. A news release featuring the quarterly results will be available on the same day at 6:30 a.m. ET. The event will be accessible on Zimmer Biomet's Investor Relations website. Interested U.S. and Canadian participants can join by calling (888) 204-4368, while international callers should dial +1 (323) 994-2093, both using conference ID 5103691. Zimmer Biomet continues to lead in medical technology, aiming to enhance patient mobility and health through innovative products and technologies.
Zimmer Biomet Holdings, a global leader in medical technology, has approved a cash dividend of $0.24 per share for Q1 2023. This dividend will be payable on April 28, 2023, to stockholders of record by the close of business on March 29, 2023. The company's commitment to returning value to shareholders demonstrates its financial health and confidence in future growth. With over 90 years in the industry, Zimmer Biomet continues to enhance patient experiences through innovative products and advanced technologies.
Zimmer Biomet (NYSE: ZBH) announced the unveiling of enhancements to its ZBEdge™ Dynamic Intelligence™ at the AAOS 2023 Annual Meeting in Las Vegas. Key updates include the mymobility® Digital Care Management Platform, which supports patient recovery through continuous data collection, and the Persona IQ®, a smart knee implant for gathering kinematic data. The ROSA® Knee system received improvements for better surgical outcomes. COO Ivan Tornos highlighted the potential of these innovations to enhance decision-making and patient care.
FAQ
What is the current stock price of Zimmer Biomet (ZBH)?
What is the market cap of Zimmer Biomet (ZBH)?
